Stay updated with breaking news from Ipid Management. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Signs of increased risk in some trials may stem from their high doses and high-CV-risk populations, propose researchers whose study saw no such concerns from normal dietary intake.
Hearing aid use was linked to a 48% slowing of cognitive decline among individuals at increased risk of dementia, results of a first-of-its-kind, randomized trial show.
The US Preventive Services Task Force said more research is needed before lipid screenings can be conducted among children with clear benefit.
The injectable agent's indications now include high-risk patients with primary dyslipidemia who are taking statins but who do not have a history of cardiovascular events.
The absolute risk reduction for a secondary endpoint was slight, but it was by almost 20% and significant and so merits further study, researchers say.